Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1NanoAlvand

02 8Bayer AG

03 1Laboratorio Eczane Pharma

04 1ORIFARM GROUP AS

05 1Pluviaendo

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Regorafenib

Brand Name : Fenosa

Dosage Form : Film Coated Tablet

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

REGORAFENIB

Brand Name : STIVARGA

Dosage Form : TABLET;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 2012-09-27

Application Number : 203085

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

REGORAFENIB

Brand Name : STIVARGA

Dosage Form : TABLET; ORAL

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 204369

Regulatory Info :

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

regorafenib

Brand Name : Stivarga

Dosage Form : FILM COATED PILL

Dosage Strength : 40 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Regorafenib

Brand Name : Stivarga

Dosage Form : Regorafenib 40Mg 84 Combined Oral Use

Dosage Strength : 84 cpr riv 40 mg vial

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Regorafenib

Brand Name : Stivarga

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 40 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Regorafenib

Brand Name : Stivarga

Dosage Form : Filmtable

Dosage Strength : 40mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

REGORAFENIB

Brand Name : STIVARGA

Dosage Form : TABLET

Dosage Strength : 40MG

Packaging : 28

Approval Date :

Application Number : 2403390

Regulatory Info : Prescription

Registration Country : Canada

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Regorafenib

Brand Name : Stivarga 40 mg

Dosage Form : TAB

Dosage Strength : 40mg

Packaging : 28X3mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Regorafenib

Brand Name : Rezitix

Dosage Form : Tablet

Dosage Strength : 40MG

Packaging : 28 Tabs

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Argentina

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Regorafenib

Brand Name : Stivarga

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 40 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Regorafenib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank